Homology Medicines

Entity > Corporation > US > Bedford Massachusetts > Homology Medicines

About Homology Medicines

Industry: Science > Biological Sciences

More information about Homology Medicines

Company Attribute Value
Address StreetAddress: Patriots Park 1, AddressLocality: Bedford, AddressRegion: Massachusetts, PostalCode: 1730, AddressCountry: United States
Founding Date 2015
Name Homology Medicines
Number Of Employees 224
Revenue $5,468,000 USD
Ticker Symbol NASDAQ: FIXX
Url homologymedicines
Linkedin linkedin
Google google
Wikidata wikidata

Homology Medicines

us

Bedford, US
14 Apr 2024

Bedford, US
14 Apr 2024

Homology Medicines

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://ir.q32bio.com › news-releases › news-release-details
Release Details - Homology Medicines - Q32 Bio
Mar 25, 2024 — Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million ... WALTHAM, Mass., March 25, 2024 / ...
https://www.fiercebiotech.com › biotech › gene-therapy...
Gene therapy biotech Homology lays off 87%, seeks options
Jul 28, 2023 — Homology Medicines has blamed the “current financing environment” for a move to lay off 87% of staff and seek a buyer for its R&D assets.
https://www.prnewswire.com › news-releases › q32-bio-a...
Q32 Bio and Homology Medicines Announce Merger ...
Nov 16, 2023 — "The proposed merger with Homology Medicines and concurrent private placement is expected to provide Q32 Bio with the capital to drive ...
https://www.biopharmadive.com › news › homology-la...
Gene editing biotech Homology hits reset and seeks a sale
Jul 28, 2023 — Homology Medicines, a biotechnology company developing genetic medicines for rare diseases, will lay off scores of its employees and stop ...
https://finance.yahoo.com › news › homology-medicin...
Homology Medicines Declares Distribution to Common ...
Mar 18, 2024 — Homology Medicines, Inc. is a clinical-stage genetic medicines company historically focused on transforming the lives of patients suffering from ...
https://www.homologymedicines.com › investigational-...
Investigational gene therapy for treatment of metachromatic ...
Investigational gene therapy for treatment of metachromatic leukodystrophy (MLD). Gingras J, St-Martin T, Gall K, et al. ASHG 2020. Homology Logo.
https://finance.yahoo.com › news › homology-medicin...
Homology Medicines Receives NASDAQ Notification ...
Jan 3, 2024 — Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement.
https://www.linkedin.com/company/homology-medicines-inc.
Homology Medicines, Inc.
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments ...
https://www.biospace.com › employer › homology-me...
Articles about Homology Medicines
Homology Medicines is based on groundbreaking science that harnesses the naturally occurring process of homologous recombination. This non-nuclease-based ...
https://investors.homologymedicines.com › news-releases
Homology Medicines Announces Proposed Public Offering ...
Apr 6, 2021 — Homology expects to grant the underwriter a 30-day option to purchase up to an additional $7.5 million of its common stock. All of the shares in ...
Related Searches
Related Searches
Homology medicines stock
homology medicines acquisition
Homology medicines careers
Google My Business
Google My Business

Homology Medicines, Inc. (Biotechnology company in Bedford, Massachusetts)

homologymedicines.com/
  • Address : 1 Patriots Park, Bedford, MA 01730
  • Phone : (781) 301-7277

Related Entities Homology Medicines

Entity Home Kalicube Pro Entity Page
Homology Medicines Entity Home Homology Medicines on Kalicube

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193953